Nanjing immunophage biotech co. ltd
WitrynaImmunophage Biotech is a Chinese high-tech pharmaceutic company which was … WitrynaNanjing Sanhome Pharmaceutical Co., Ltd. 187 followers on LinkedIn. Sanhome …
Nanjing immunophage biotech co. ltd
Did you know?
Witryna13 lut 2024 · This page is part of the FAQs on Testing for SARS-CoV-2 and provides … Witryna5 maj 2024 · Immunophage Biotech, a Nanjing-based pharmaceutic company, has recently completed a Pre-A round of financing of nearly RMB100 million (US$14.2 million), led by Jinfang Hongrui Investment …
WitrynaWe have developed a monoclonal antibody antagonist of CCR8, IPG0521, which potently inhibited the receptor-mediated signaling and chemotaxis in Treg cells with single digital nanomolar IC50. IPG0521 potently inhibited the growth of multiple tumor types in both syngeinic and immune-humanized mouse models, including lung cancer, liver cancer ... WitrynaBioHeng is a clinical biopharmaceutical and biotechnology Company focuses on novel immunotherapy and next-generation gene therapy development for treating cancers and various diseases. Founded in 2024, Bioheng has established a high standard GMP grade clinical translational center, and is leading in the field of cell engineering, proliferation ...
WitrynaWe are a R&D focused innovative biotechnology company with both capabilities in …
WitrynaImmunophage Biotech has raised a total of $43.4M in funding over 4 rounds. Their …
Witryna19 maj 2024 · Filed: March 13, 2024 Publication date: May 12, 2024 Applicant: NANJING IMMUNOPHAGE BIOTECH CO., LTD. Inventors: Kin Chiu FONG, Hongyu YANG, Ping DU, Jinfu YANG COMPOUNDS USEFUL TO TREAT INFLUENZA VIRUS INFECTIONS Publication number: 20240127282 st mary\u0027s parish navanWitrynaImmunophage Biotech has raised a total of $43.4M in funding over 4 rounds. Their latest funding was raised on Mar 13, 2024 from a Series B round. Immunophage Biotech is funded by 11 investors. Zhongbo Juli and Med-Fine Capital are the most recent investors. Funding Rounds Number of Funding Rounds 4 Total Funding … st mary\u0027s parish prince george bcWitryna8 lis 2024 · Nanjing Immunophage Biotech Co., Ltd: ClinicalTrials.gov Identifier: … st mary\u0027s parish milford maWitrynaNanjing Sanhome Pharmaceutical Co., Ltd. 187 followers on LinkedIn. Sanhome was founded in 1996, and aims to let more people to enjoy healthy happiness. ... Immunophage Biotech Co. Ltd ... st mary\u0027s parish primary school greensboroughWitrynaNanjing Daoge Biomedical Technology Co., Ltd is a company specializing in custom … st mary\u0027s parish sandyfordWitryna11 maj 2024 · Nanjing aimeifei Biomedical Technology Co., Ltd. 艾美斐是一家靶点创新药研发商，公司致力开发治疗恶性肿瘤、自身免疫性疾病、代谢性疾病和神经退行性疾病等重大疾病的小分子或大分子新药。. 主要涉及医学、药理学、药物化学、药代动力学、生物靶标等领域。. st mary\u0027s parish tillsonburgWitrynaImmunophage Biotech Co., Ltd. 2024 年 12 月 - 2024 年 6 月7 个月 中国 上海 Business Development Director Shanghai Mabgeek Biotech.Co., Ltd 2024 年 7 月 - 2024 年 12 月1 年 6 个月 中国 上海 BD Manager... st mary\u0027s parish north sydney